<p>&nbsp;</p><p><strong>Conclusion:</strong> We identified the representativeness of HIV case-based surveillance from public health facilities in which Anti-Retroviral Therapy was good but the non-inclusion of facilities that were not Anti-Retroviral Therapy sites and private health facilities to participate in the HIV surveillance system. We recommended that the utilization of HIV case-based surveillance data should strengthen for decision-making at the site level and above the site level.&nbsp;</p>